Basta, Nermine O
Halliday, Gail C
Makin, Guy
Birch, Jillian
Feltbower, Richard
Bown, Nick
Elliott, Martin
Moreno, Lucas
Barone, Giuseppe
Pearson, Andrew DJ
James, Peter W
Tweddle, Deborah A
McNally, Richard JQ
Article History
Revised: 11 July 2016
Accepted: 29 August 2016
First Online: 4 October 2016
Competing interests
: Dr Lucas Moreno discloses the following activities: consultancy/advisory board participation for Novartis, AstraZeneca, RocheGenentech, Mundipharma and Bayer. The remaining authors declare no conflict of interest.